Market Research Blog

Future Market Insights (FMI) has recently published an exhaustive yet unbiased study on the global fiducial markers market elaborating on the vital dynamics responsible for shaping future growth trajectory for the forecast period ranging from 2020-2030.

According to the American Cancer Society, in 2019, approximately 174,650 men were diagnosed with prostate cancer, up by 6% from 2018. It is also the second leading cause of deaths among American men, with over 33,000 fatalities expected by 2020-end.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-12825

Therefore, manufacturers are likely to find immense opportunities with respect to introducing fiducial markers to aid in eradicating this deadly disease across potential regions. Recent research has paved the way for non-implantable fiducial markers using the cone-beam CT technology.

Key Takeaways

• Global fiducial markers market to reach US$ 258.8 Mn by 2030, expanding at over 8% CAGR
• Pure gold fiducial markers to capture lion’s share, expected to generated over 60% revenue by 2020-end
• By modality, photon treatment is expected to generate an absolute opportunity worth US$ 12 Mn through 2030
• Maximum uptake likely across the prostate cancer segment, accounting for over 7 out of 10 fiducial marker applications
• Radiotherapy centers to remain primary end-users of fiducial markers due to deployment of specialized cancer treatments
• Europe and North America to capture an impressive market share, East Asia following closely

“Increasing research and development for discovering technologically advanced solutions to treat cancers and other debilitating disorders is generating immense green space for potential fiducial markers market players,” says the FMI analyst.

COVID-19 Impact Analysis

The COVID-19 pandemic has widened growth prospects for the global fiducial markers market. As cancer treatment acquires precedence, healthcare providers are making accommodations to address patients suffering from debilitating conditions. Consequently, the need for precision-based detection systems has aggrandized in recent months.

Amid strict hygiene and social distancing protocols, healthcare providers are conducting radiation and chemotherapy procedures, leading to increased uptake of fiducial markers. Moreover, to reduce infection risks, patients requiring immediate surgical care are attended to first while consultation for possible prevalence have been shifted to virtual platforms.

Competitive Landscape

The global fiducial markers market comprises of the following prominent players: Eckert & Ziegler BEBIG, Innovative Oncology Solutions, Boston Scientific, IBA Dosimetry, Best Medical International, Inc., Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi A/S, and Stellar Medical to name a few.

A combination of expansion strategies, ranging from new product launches to strategic collaborations and alliances and technological disruptions are employed by these manufacturers to stay afloat in this highly competitive environment.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-12825

Innovative Oncology Solutions, for instance, markets the FLEXIMARC G/T Specialty Fiducial Markers, consisting of two 1.2 mm x 3 mm gold nodes separated by a thin, medical grade titanium filament which is optimized for MRI visibility. This permits soft tissue to anchor the marker in place, reducing chances of migration.

With regard to technological advancements, IBA Dosimetry announced the launch of its myQA iON radiation therapy integrated quality assurance (QA) platform in 2019. This platform incorporates process automation, task-based workflows and PT machine log files to streamline cancer treatment procedures.

Global mammalian transient protein market revenues are projected to surpass US$ 540 million in 2020, according to a new study by Future Market Insights (FMI). The report also states that, innovations in automation and recombinant proteins will support market developments, however, prohibitive costs and complexity to maintain media purity remain challenges.

Key Takeaways on Mammalian Transient Protein Expression Market

• The size of the mammalian transient protein expression market is estimated to reach approximately US$ 540 Mn by the end of 2020, with antibody and therapeutic protein production applications being the primary factors driving growth in the industry.
• Biopharmaceutical companies will remain prominent end-users of mammalian transient protein expression, while CROs are also likely to reflect steady growth on the back of biologics and drug development endeavours.
• Chinese hamster ovary cells in terms of cell lines reflect relatively higher demand, owing to applications in academic and research uses, accounting for ~70% of market share by 2030.
• North America followed by Europe are leading markets for mammalian transient protein expression, access to cutting edge healthcare technologies, and the presence of leading market players.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-12807

Covid-19 Impact on Mammalian Transient Protein Expression Market

The Impact of the covid-19 pandemic on the mammalian transient protein expression market has largely been negative. Strict lockdown and social distancing regulations has resulted in delayed projects in research and biomedicine applications.

Also, market players have witnessed lower sales and revenue during the crisis period arising from supply chain disruptions, and shortage of adequate manpower. On the other hand, potential for applications in vaccine development is likely to provide opportunities for short-term growth, moderately mitigating loss during this period.

Who is Winning?

In its latest report, Future Market Insights has provided details on key business strategies that are gaining importance in the mammalian transient protein expression market. Market leaders in the industry have been pushing on the expansion of their portfolios with offerings associated to antibody development and gene coding. Also, strategic collaborations are gaining ground in the sector.

Merck KgaA, Thermo Fisher Scientific, Agilent Technologies Inc., Lonza, Mirus Bio Inc., Takara Bio Inc., Qiagen N.V., and Bio-Rad Laboratories Inc., are some of the key companies operating in the mammalian transient protein expression market.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12807

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Future Market Insights offers a 10-year forecast for the North America outbound medical tourism services market. The primary objective of the report is to offer updates and information related to market opportunities in the North America outbound medical tourism services market. Our study demonstrates key market dynamics expected to influence the current environment and future status of the North America outbound medical tourism services market over the forecast period (2016 – 2026). In this report, we present useful insights on key trends, drivers, restraints, value forecasts, and opportunities for companies operating in the North America outbound medical tourism services market.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-na-2158

Report description

To understand and assess opportunities in the North America outbound medical tourism services market, we have presented the market forecast for the different therapeutic applications (Cosmetic Surgery Treatment, Dental Treatment, Cardiovascular Treatment, Orthopaedic Treatment, Cancer Treatment, Fertility Treatment, Weight Loss Treatment, Spinal Surgery Treatment, Neurology Treatment, Other General Treatment) across the two major North American countries U.S and Canada. The report provides analysis of the North America outbound medical tourism services market in terms of market value (US$ Mn) and volume.

The report begins with the market definition followed by definitions of the different outbound medical tourism services and different therapeutic applications. The market dynamics section includes our in-depth analysis of the key trends, drivers, restraints, opportunities, and macro-economic factors influencing the growth of the North America outbound medical tourism services market. The subsequent sections analyse the North America outbound medical tourism services market on the basis of therapeutic applications and countries and present a comprehensive market forecast in terms of value for the next 10 years. Our study further discusses key trends within the two countries contributing to the growth of the regional market and analyses the degree to which drivers are influencing the market in each region.

In the final section of the report, we have included a competitive landscape to provide a dashboard view of key companies operating in the North America outbound medical tourism services market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the North America outbound medical tourism services market and the potential players. This section also includes market strategies and a SWOT analysis of the main players operational in the North America outbound medical tourism services market. We have also covered detailed profiles of the key players operating in the North America outbound medical tourism services market to evaluate their long- and short-term strategies, key offerings, and recent developments in the North America outbound medical tourism services market.

Research methodology

We have leveraged extensive secondary research to ascertain overall market size and top industry players. Critical market data has also been acquired through personal interviews with key stakeholders in the North America outbound medical tourism services market. Data gathered through comprehensive primary and secondary research has been validated by the triangulation method and further scrutinised using advanced tools to arrive at useful qualitative and quantitative insights. Given the ever-fluctuating nature of the global economy, we have not only conducted our forecasts in terms of CAGR, but have also analysed the market on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities across the North America outbound medical tourism services market.

Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-na-2158

Another important feature of our report is the analysis of key market segments in terms of absolute dollar opportunity, critical in assessing the level of opportunity that a provider can look to achieve as well as to identify potential resources from a sales and delivery perspective for services offered by the North America outbound medical tourism services market. Further, to understand key segments in terms of growth and performance in the North America outbound medical tourism services market, Future Market Insights has developed a market attractiveness index to help providers identify existing market opportunities across the North America outbound medical tourism services market.

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Mammalian Transient Protein Expression Market – The mammalian transient protein expression market has reflected steady growth on the back of growing demand from the biomedicine sector. Efforts into vaccine development continue to create possibilities for new opportunities.

In Vitro Fertilization Banking Services Market – According to the Centers for Disease Control and Prevention (CDC), about 10% of women in the United States between ages 15 to 44 years have infertility while the rate of male infertility is 4.5-6% in North America.

Cryopreservation for In-vitro Fertilization (IVF) Market – According to analysis by Future Market Insights (FMI), cryopreservation for IVF market surpassed a valuation of US$ 339 million in 2019. The market is set to reflect an impressive 10.2% CAGR through 2030.

The global rapid infusers market has relatively less impacted by the COVID-19 pandemic, with a new report by Future Market Insights (FMI) estimating market revenues to grow at 4.5% through 2030. While growing focus on advanced and novel care is driving growth, high cost, combined with concerns about efficacy continue to limit adoption.

Key Takeaways

• Market revenues will surpass USD 817 million, with anaesthesia, and emergency healthcare applications being the primary driving factors
• Hospitals will remain the leading end users, while ASCs are also likely to reflect steady growth on the back of growing adoption in outpatient medical procedures.
• Trolley mounted offerings continue to witness market preference, owing to portability and ease of use in hospital settings, accounting for ~70% of market share.
• North America followed by Europe, are leading regional markets for rapid infusers, supported by the massive investments into the healthcare sector, and easier access to new hospital and emergency care technologies.

“The global market for rapid infusers is driven by growing number of surgical procedures and high risk of hypothermia and hypovolemia. This product is also widely considered an important intervention in life-threatening ailments such as sepsis. These issues are major influencers in terms of market development through the forecast period,” said a lead analyst from FMI.

Discover more about report analysis with figures and data tables, along with the table of contents. Ask an Analyst- https://www.futuremarketinsights.com/ask-question/rep-gb-6716

Covid-19 Impact on Rapid Infusers Market

The COVID-19 pandemic is expected to marginally impact the rapid infusers market. Demand largely remains stable as rapid infusers are standard equipment in most healthcare facilities for critical care applications. The demand for reusable rapid infusers is likely to fall in favor of single-use alternatives, owing to concerns over viral transmission.

Potential disruptions of raw material and component supplies due to lockdown and trade restrictions are concerns. However, the essential natures of the products, makes the industry largely exempt from government restrictions. Demand is unlikely to change substantially even in the post-pandemic period as applications in urology, gynecology, and ICUs continue unabated.

Who is Winning?

In a new report, Future Market Insights has provided comprehensive details on essential business strategies that find roles in the rapid infusers market. Market leaders in the industry have been emphasizing on the expansion of their portfolios with efforts on product research. Also, strategic acquisitions are gaining ground in the industry.

Contact Sales for Further Assistance in Purchasing this Report- https://www.futuremarketinsights.com/checkout/6716 

3M, GE Healthcare Inc., ZOLL Medical Corporation, Stryker Corporation, Teleflex Incorporated, Smith’s Group plc, Soma Technology Inc., Smisson-Cartledge Biomedical, and Becton, Dickinson and Company are some of the key companies operating in the rapid infuser market.

More Insights

The Future Market Insights report has given readers a detailed analysis of the global rapid infusers market, with critical information on historical demand (2015-2019) and for forecast statistics (2020 – 2030). The report also encompasses a detailed analysis in terms of costs, pricing, and other major dynamic factors that influence tech developments and production decisions for rapid infusers in varied healthcare applications.

The global in vitro fertilization banking services market is slated to exhibit a robust CAGR of 11% over the assessment period of 2020-2030. This growth can be predominantly attributed to growing cases of infertility all over the world on account of work pressure, stress, food habit, changing lifestyle, and others, the need for IVF, ICSI (Intracytoplasmic Sperm Injectiom), and others has augmented significantly. This consecutively is boosting the market growth.

The in vitro fertilization banking services market, despite undergoing a temporary period of lull due to COVID-19 outbreak, is likely to have an impressive growth trajectory between 2020 and 2030.

Besides lucrative prospects in Europe, the market will continue witnessing high demand in East Asia. Expansion of healthcare sectors in high potential markets will remain a chief growth driver. Future Market Insight’s (FMI’s) study on the in vitro fertilization banking services market uncovers hidden opportunities besides presenting a refined forecast for the assessment period.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-12789

“Launching advanced IVF techniques for instance, three parent IVF, genetic diagnosis, three-parent, percutaneous epidydimal sperm aspiration, along with others are considered innovatory findings in the field of medicine. Furthermore the growing predominance of fertility concerns, rising awareness amid patients and their willingness to expend on advanced treatment procedures is likely to generate lucrative development prospects for the market.” says an FMI analyst.

In Vitro Fertilization Banking Services Market – Key Highlights

• Europe to sustain its prevalent position throughout the forecast period due to growing rate of infertility in the region.
• Egg banking will lead among service type segment in the global market.
• Growing demand for andrology services is anticipated to expand expansion prospects.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-12789

Drivers

• Rise in infertility rate across the globe due to lifestyle, stress, and others is likely to spur market growth.
• Increasing cases of cancer has resulted in infertility rate among women and men, thus ensuing in surging demand for in vitro fertilization.
• Increasing investment to obtain secure and safe egg/sperm storage facility together with the growing focus on cost-efficient services is bolstering the market growth.

Restraints

• Restricted adoption of the services owing to being time consuming and costly, limits market growth over the forecast period.
• Risks related to IVF process such as egg-retrieval procedure complications, ovarian hyperstimulation syndrome, along with others work as the constraint for the market growth.

COVID-19 Impact on the Market

The market has been adversely impacted by the COVID-19 outbreak as it is a costly and time consuming procedure. As the attention in healthcare sector shifted towards emergency services, the demand for has been dropped substantially impacting the market growth. However, the market is anticipated to get back to its feet by 2021 end generating abundant opportunities for the key players.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/12789

Competitive Landscape

FMI opines that the in vitro fertilization banking services market is expanding fast, the key market players are projected to face harsher competition amid the assessment period. Some of the major players include MyEggBank, The World Egg Bank, Cryos International, Fairfax Cryo Bank, Seattle Sperm Bank, European Sperm Bank, Boston IVF´s network and CCRM´s network.

The global cryopreservation for in-vitro fertilization (IVF) market is likely to grow steadily with substantial improvements to pregnancy success rates in long term storage for reproductive materials. Favorable changes in regulations toward single parents, same sex couples, and older couples will create opportunities.

According to analysis by Future Market Insights (FMI), cryopreservation for IVF market surpassed a valuation of US$ 339 million in 2019. The market is set to reflect an impressive 10.2% CAGR through 2030.